SML3116
BMS-378806
≥98% (HPLC)
동의어(들):
1-[(2R )-4-Benzoyl-2-methyl-1-piperazinyl]-2-(4-methoxy-1H -pyrrolo[2,3-b ]pyridin-3-yl)-1,2-ethanedione, 4-Benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine, BMS 378806, BMS 806, BMS-806, BMS378806, BMS806
로그인조직 및 계약 가격 보기
모든 사진(1)
크기 선택
보기 변경
10 MG
₩124,439
50 MG
₩501,918
About This Item
실험식(Hill 표기법):
C22H22N4O4
CAS Number:
Molecular Weight:
406.43
MDL number:
UNSPSC 코드:
12352107
NACRES:
NA.77
추천 제품
Quality Level
분석
≥98% (HPLC)
양식
powder
색상
white to gray
solubility
DMSO: 2 mg/mL, clear
저장 온도
2-8°C
SMILES string
O=C(N1[C@@H](CN(CC1)C(C2=CC=CC=C2)=O)C)C(C3=CNC4=NC=CC(OC)=C34)=O
InChI
1S/C22H22N4O4/c1-14-13-25(21(28)15-6-4-3-5-7-15)10-11-26(14)22(29)19(27)16-12-24-20-18(16)17(30-2)8-9-23-20/h3-9,12,14H,10-11,13H2,1-2H3,(H,23,24)/t14-/m1/s1
InChI key
OKGPFTLYBPQBIX-CQSZACIVSA-N
일반 설명
생화학적/생리학적 작용
BMS-378806 (BMS-806) is a potent and selective HIV-1 attachment inhibitor that blocks HIV glycoprotein 120 (gp120) from interacting with host T-cell surface glycoprotein CD4 (IC50 = 100 nM against CD4 for binding gp120; CYP1A2/2C9/2C19/2D6/3A4 IC50 >23 μM) without affecting HIV integrase, protease, or reverse transcriptase activity. BMS-806 effectively prevents various HIV-1 isolates from replication (EC50 from 0.85 to 26.5 nM in MT-2 and PM1 cultures; host cytotoxicity IC50 >300 μM) without affecting HIV-2, SIV, MuLV, RSV, HCMV, BVDV, VSV, or influenza virus.
Potent and selective HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions and protects against HIV-1 infection in host cultures.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Flash Point (°F)
Not applicable
Flash Point (°C)
Not applicable
가장 최신 버전 중 하나를 선택하세요:
Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry
Y.-J. Xue, et al.
Journal of Separation Science (2007)
Tao Wang et al.
Journal of medicinal chemistry, 46(20), 4236-4239 (2003-09-19)
Indole derivative 1 interferes with the interaction of the HIV surface protein gp120 with the host cell receptor CD4. The 4-fluoro derivative 2 exhibited markedly enhanced potency and was bioavailable in the rat, dog, and cynomolgus monkey when administered orally
Yuta Hikichi et al.
mBio, 12(1) (2021-01-14)
Despite the effectiveness of antiretroviral (ARV) therapy, virological failure can occur in some HIV-1-infected patients in the absence of mutations in drug target genes. We previously reported that, in vitro, the lab-adapted HIV-1 NL4-3 strain can acquire resistance to the
A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding
Pin-Fang Lin, et al.
Proceedings of the National Science Council, Republic of China / Applied Science, 100(19), 11013-11018 (2003)
Prediction of the binding mode between BMS-378806 and HIV-1 gp120 by docking and molecular dynamics simulation
Ren K, et al.
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 766-772 (2006)
활성 필터
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.
